Cellistic Logo
  • CDMO Services
    • Cell Line Development
    • Process Development
    • Analytical Development
    • Master Cell Banking
    • Tech Transfer
    • GMP Manufacturing
    • QC Testing
  • Platforms & Technologies
    • Allo Chassis™
    • STAR-CRISPR™
    • Pulse Cell Line Development Platform
    • Cellistic’s Echo Manufacturing Platform
  • GMP Manufacturing
    • Echo™-NK
    • Echo™-Cardio
    • Echo™-Endothelial
    • Echo™-T
  • Facility
  • Expert Insights
    • Announcements
    • Expert Opinion
    • Interviews
    • Podcasts
    • Posters
    • Webinars
  • About
    • Team
    • Careers
    • Events
Contact
Cellistic Logo
  • CDMO Services
    • Cell Line Development
    • Process Development
    • Analytical Development
    • Master Cell Banking
    • Tech Transfer
    • GMP Manufacturing
    • QC Testing
  • Platforms & Technologies
    • Allo Chassis™
    • STAR-CRISPR™
    • Pulse Cell Line Development Platform
    • Cellistic’s Echo Manufacturing Platform
  • GMP Manufacturing
    • Echo™-NK
    • Echo™-Cardio
    • Echo™-Endothelial
    • Echo™-T
  • Facility
  • Expert Insights
    • Announcements
    • Expert Opinion
    • Interviews
    • Podcasts
    • Posters
    • Webinars
  • About
    • Team
    • Careers
    • Events

Expert Opinion

All Announcements Events Expert Opinion Interviews Podcasts Posters Webinars
Summary of the Whitepaper on Building Blocks for Cell & Gene Therapy (CGT)

July 8, 2024

Summary of the Whitepaper on Building Blocks for Cell & Gene Therapy (CGT)

The whitepaper, a collaboration between the Alliance for Regenerative Medicine (ARM) and the ...

IP Considerations for Gene Editing in the Cell Therapy space

June 10, 2024

IP Considerations for Gene Editing in the Cell Therapy space

Gene editing for cell therapies and, in particular, for iPSC-derived cell therapies have ...

Enhancing precision in iPSC Allogeneic Cell Therapy through advanced gene-editing strategies

May 14, 2024

Enhancing precision in iPSC Allogeneic Cell Therapy through advanced ...

Induced pluripotent stem cells (iPSCs) have recently emerged as a promising avenue for ...

Converting iPSC to T Cells: Key Challenges and Considerations

March 12, 2024

Converting iPSC to T Cells: Key Challenges and Considerations

Chimeric antigen receptor (CAR)-engineered T cells (CAR-T) have been remarkably successful in ...

Shifting Tides: Unleashing the Potential of iPSC-Based Allogeneic Cell Therapy

August 29, 2023

Shifting Tides: Unleashing the Potential of iPSC-Based Allogeneic Cell ...

As the limitations of autologous cell therapy approaches become evident, many cell therapy ...

The benefits of allogeneic cell therapy

November 10, 2022

The benefits of allogeneic cell therapy

Cell therapies hold great promise as new medical interventions. Diseases that until recently ...

← 1 2 3 4
Cellistic Logo White
  • Services
  • Technologies
  • Cell Types
  • Facility
  • Resources
  • About
  • Contact
  • Team
  • Careers
x-twitter InBug-White-1

Rue Edouard Belin 2
1435 Mont-Saint-Guibert
Belgium

 

partnering@cellistic.com

  • Privacy Policy
  • Cookie Policy